93P Patient-reported outcomes (PROs) with cemiplimab or placebo plus platinum-doublet chemotherapy (chemo) for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): EMPOWER-Lung 3 trial
Title:
93P Patient-reported outcomes (PROs) with cemiplimab or placebo plus platinum-doublet chemotherapy (chemo) for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): EMPOWER-Lung 3 trial
Author:
Makharadze, T. Quek, R.G. Melkadze, T. Gogishvili, M. Ivanescu, C. Giorgadze, D. Dvorkin, M. Penkov, K. Laktionov, K. Nemsadze, G. Nechaeva, M. Rozhkova, I. Kalinka, E. Gessner, C. Moreno-Jaime, B. Passalacqua, R. Konidaris, G. Rietschel, P. Gullo, G.